CAH

CAH

USD

Cardinal Health Inc. Common Stock

$195.340+4.910 (2.578%)

Reaalajas hind

Healthcare
Medical Distribution
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$190.430

Kõrge

$196.960

Madal

$189.980

Maht

1.20M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

46.4B

Tööstusharu

Medical Distribution

Riik

United States

Kauplemisstatistika

Keskmine maht

2.51M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $110.63Praegune $195.340Kõrge $197.67

Seotud uudised

PR Newswire

Cardinal Health Board of Directors Approves Quarterly Dividend

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's...

Vaata rohkem
Cardinal Health Board of Directors Approves Quarterly Dividend
Analyst Upgrades

Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $210

Mizuho analyst Steven Valiquette maintains Cardinal Health with a Outperform and raises the price target from $170 to $210.

Vaata rohkem
Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $210
Analyst Upgrades

TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $225

TD Cowen analyst Charles Rhyee maintains Cardinal Health with a Buy and raises the price target from $183 to $225.

Vaata rohkem
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $225
PR Newswire

Cardinal Health completes acquisition of Solaris Health

Cardinal Health (NYSE: CAH) announced today that it has completed its acquisition of Solaris Health, the country's leading urology MSO. Solaris...

Vaata rohkem
Cardinal Health completes acquisition of Solaris Health
Analyst Upgrades

Citigroup Maintains Neutral on Cardinal Health, Raises Price Target to $190

Citigroup analyst Daniel Grosslight maintains Cardinal Health with a Neutral and raises the price target from $165 to $190.

Vaata rohkem
Citigroup Maintains Neutral on Cardinal Health, Raises Price Target to $190
Analyst Upgrades

UBS Maintains Buy on Cardinal Health, Raises Price Target to $220

UBS analyst Kevin Caliendo maintains Cardinal Health with a Buy and raises the price target from $185 to $220.

Analyst Upgrades

Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $220

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health with a Outperform and raises the price target from $190 to $220.

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.